RevelAi Health, a conversational AI-based platform built for musculoskeletal care, announced it has closed an oversubscribed $3.1 million seed round led by Ulu Ventures and Symphonic Capital, with participation from Orthopedic VC, Sand Hill Angels, and a consortium of nationally recognized orthopedic surgeons.
Impact of musculoskeletal disorders: Musculoskeletal disorders now account for the largest share of U.S. healthcare spending, while the country faces a massive shortage of physicians. And the Centers for Medicare & Medicaid Services (CMS) is moving hospitals toward mandatory downside-risk bundles for joint replacement, fracture care, and other orthopedic episodes, aiming for universal value-based coverage by 2030.
What RevelAi does: RevelAi works as a 24/7 virtual care navigator for orthopedic practices and care organizations. And it answers calls with evidence-based triage, collects mandated quality reporting questionnaires by voice or text, and converts every phone, video, or in-person encounter into a structured note with clinical documentation codes and automated risk flags.
Episode-wide workflows trigger Principal Care Management, Transitional Care Management, and preoperative optimization tasks that align each patient’s journey with CMS’ new Transforming Episode Accountability Model (TEAM) bundled payment model and other value-based initiatives—without extra staff clicks. And all clinical content and decision logic are continuously refined by RevelAi’s advisory group of board-certified orthopedic surgeons, ensuring each recommendation remains guideline-concordant and purpose-built to accelerate value-based musculoskeletal care.
How the funding will be used: The seed funding will enhance electronic health record and practice-management integrations, expand the company’s library of AI-collected outcome surveys and risk pathways, expand the engineering and research teams, and accelerate collaborations with health systems, specialty societies, and ambulatory surgery center networks.
KEY QUOTES:
“Musculoskeletal care is shifting from single-visit encounters to population-level accountability just as clinical teams are stretched thin. RevelAi gives organizations an AI-first operating layer that lets them succeed in that reality.”
Christian Pean, MD, MS, orthopedic trauma surgeon, faculty member at the Duke-Margolis Institute for Health Policy, and Founder & Chief Executive Officer of RevelAi Health
“RevelAi’s AI agents close care gaps, curb avoidable emergency department visits, and simplify quality reporting—without adding staff.”
Ronald Delanois, MD, Chairman of the Rubin Institute for Advanced Orthopedics at LifeBridge Health in Baltimore, Maryland
“From my perspective, conversational AI is essential for succeeding in value-based mandates like the Transforming Episode Accountability Model.”
Joseph Zuckerman, MD, Chair of Orthopedic Surgery at NYU Langone Health
“RevelAi has already automated thousands of care conversations. They’re proving AI-powered orchestration can scale now, lightening clinicians’ workload and elevating the patient experience. We’re proud to back a team poised to become the essential AI backbone for modern health systems.”
Clint Korver, Managing Director at Ulu Ventures
“We’re building the AI console that turns every touchpoint into coordinated action.”
Hadi Javeed, Co-Founder and Chief Technology Officer
